Neurocristopathy
Neurocristopathy is a term used to describe a group of pathologies in humans that are caused by abnormal development, migration, differentiation or survival of neural crest cells (NCCs). These cells are a transient, multipotent, migratory cell population unique to vertebrates that gives rise to a diverse cell lineage including melanocytes, craniofacial cartilage and bone, smooth muscle, peripheral and enteric neurons and glia.
Etiology[edit]
The etiology of neurocristopathies is complex and multifactorial. It involves genetic and environmental factors. Genetic factors include mutations in genes that are important for the development and function of neural crest cells. Environmental factors include exposure to teratogens during pregnancy.
Clinical Presentation[edit]
The clinical presentation of neurocristopathies is diverse and depends on the specific disorder. However, common features include pigmentation abnormalities, craniofacial anomalies, heart defects, and neurological abnormalities.
Diagnosis[edit]
Diagnosis of neurocristopathies often involves a combination of clinical examination, imaging studies, and genetic testing. The specific tests used depend on the suspected disorder.
Treatment[edit]
Treatment of neurocristopathies is largely supportive and depends on the specific disorder and the severity of symptoms. It often involves a multidisciplinary team of healthcare providers.
Prognosis[edit]
The prognosis of neurocristopathies varies widely and depends on the specific disorder and the severity of symptoms. Some individuals with mild forms of these disorders live normal, healthy lives, while others with severe forms may have significant health problems and shortened life spans.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
